» Articles » PMID: 30578029

Higher Adherence to Plant-based Diets Are Associated with Lower Likelihood of Fatty Liver

Overview
Journal Clin Nutr
Publisher Elsevier
Date 2018 Dec 23
PMID 30578029
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Some plant-based diets have been suggested to have a beneficial impact on liver disease risk. We examined the association of the overall plant-based diet (PDI), hypothesized healthful PDI (hPDI) and unhealthful PDI (uPDI) with non-alcoholic fatty liver disease (NAFLD) in US adults from the 2005-2010 National Health and Nutrition Examination Survey (NHANES2005-2010). Analysis of covariance, linear and logistic regression models accounted for the survey design and sample weights. Overall, 18,345 participants were included, with a mean age of 47.9 years and comprising 51.7% women. Liver function tests including alanine aminotransferase (ALT), aspartate aminotransferase (AST) and fatty liver index (FLI) decreased across increasing thirds of PDI and hPDI (all p < 0.001), while adjusted mean of ALT, AST and FLI increased across increasing thirds of uPDI. Adjusted linear regressions showed that PDI and hPDI had negative and significant associations with ALT (PDI = β:-0.095, hPDI = β:-0.128), AST (PDI = β:-0.101, hPDI = β:-0.138) and FLI (PDI = β:-0.153, hPDI = β:-0.265), while uPDI had a positive and significant association with ALT (β: 0.103), AST (β: 0.112) and FLI (β: 0.241). After adjustment, participants in the upper third of PDI had 21% lower odd of NAFLD compared with those in the lowest third [odds ratio (OR): 0.79, 95% confidence interval (95%CI): 0.74-0.82]. A similar trend was observed with hPDI; and the opposite across increasing thirds of uPDI. Our findings confirm that healthy plant-based diets are associated with lower NAFLD risk and more favorable liver function tests profile.

Citing Articles

Effects of time restricted feeding combined with Lacto Ovo vegetarian diet on metabolic associated fatty liver disease management: a randomized clinical trial.

Shafiee M, Sadeghi A, Ghafouri-Taleghani F, Nilghaz M, Ghods M, Narimani B Sci Rep. 2025; 15(1):4463.

PMID: 39915600 PMC: 11803106. DOI: 10.1038/s41598-025-88773-z.


Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies.

Monti E, Vianello C, Leoni I, Galvani G, Lippolis A, DAmico F Cells. 2025; 14(2).

PMID: 39851512 PMC: 11764391. DOI: 10.3390/cells14020084.


A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Castelnuovo G, Perez-Diaz-Del-Campo N, Rosso C, Armandi A, Caviglia G, Bugianesi E Nutrients. 2024; 16(13).

PMID: 38999775 PMC: 11243448. DOI: 10.3390/nu16132027.


Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective.

Keating S, Chawla Y, De A, George E Hepatol Int. 2024; 18(Suppl 2):959-976.

PMID: 38717691 PMC: 11450077. DOI: 10.1007/s12072-024-10663-9.


Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity: A Systematic Review and Meta-Analysis.

Dobbie L, Burgess J, Hamid A, Nevitt S, Hydes T, Alam U Nutrients. 2024; 16(7).

PMID: 38613063 PMC: 11013586. DOI: 10.3390/nu16071030.